Skip to main content
Clinical Trials/NCT03678220
NCT03678220
Unknown
Not Applicable

Clinical Translation of Augmented Reality Visualization for Laparoscopic Surgery

IGI Technologies, Inc.1 site in 1 country30 target enrollmentApril 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Laparoscopic Hepatectomy
Sponsor
IGI Technologies, Inc.
Enrollment
30
Locations
1
Primary Endpoint
Surgeon interview regarding usability
Last Updated
7 years ago

Overview

Brief Summary

The objective of this study is to test the technical feasibility of LapAR visualization system for guiding laparoscopic surgeries and to gather clinical feedback on the use of this tool.

Detailed Description

Surgeons use real-time video generated by a laparoscope to visualize the operative field when performing laparoscopic procedures. An inability to see beneath organ surfaces is a limitation of the current visualization technology. Surgeons additionally use laparoscopic ultrasound to see beneath organ surfaces, but also need to mentally correlate the ultrasound image with the video of the operative field. This process is difficult, subjective, and variable with expertise, and discourages the use of ultrasound. The investigators have developed a method to combine live laparoscopic video and laparoscopic ultrasound images to present fused multimodality images on a single display, eliminating the need for mental image correlation. Specifically, the image fusion method, called laparoscopic augmented reality (LapAR), augments the laparoscopic video with ultrasound data when required by surgeons. This study is designed to test this minimal-risk capability in patients referred for relevant laparoscopic procedures.

Registry
clinicaltrials.gov
Start Date
April 1, 2019
End Date
March 1, 2020
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
IGI Technologies, Inc.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient is referred for either laparoscopic partial hepatectomy for tumor removal or laparoscopic ablation of liver cancer;
  • Patient must be at least 18 years old;
  • Patient provides written consent;
  • Patient is considered a suitable candidate based on tumor location for using the AR system.

Exclusion Criteria

  • Patients with pacemaker or any other ICD(intra-cardiac device) which may interfere with electromagnetic tracking

Outcomes

Primary Outcomes

Surgeon interview regarding usability

Time Frame: post surgery, an expected average of 5 minutes

The ease of use of the LapAR system will be evaluated by the surgeon

Procedure time

Time Frame: during surgery

Time of using the LapAR system for laparoscopic hepatectomy and laparoscopic thermal ablation

Measurement of margin

Time Frame: post surgery

Obtain from Pathology department or follow-up imaging

Secondary Outcomes

  • System set-up time(before surgery, an expected average of 15 min)

Study Sites (1)

Loading locations...

Similar Trials